AIM ImmunoTech CEO to Participate in Two Upcoming Investor

OCALA, Fla., Dec. 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas Equels, Chief Executive Officer of...

Related Keywords

United States ,American ,Maulik Shah ,Thomas Equels ,Immunotech Inc ,Crescendo Communications ,Chief Executive Officer ,Applied Ingenuity ,Bioflorida Conference ,Benzinga All Access ,Benzinga All Access Show ,All Access ,Nyse Aim ,Aim Immunotech Inc ,Covid 19 ,